Diagnostic terminology used to describe atypia on breast core needle biopsy: correlation with excision and upgrade rates

• Main Authors: Gary Tozbikian, Michael George, Debra L. Zynger
• Format: Article
• Language: English
• Published: BMC 2019-06-01
• Series: Diagnostic Pathology
• Subjects: Breast; Atypical ductal hyperplasia; Atypia; Upgrade; Excision; Rate
• Online Access: http://link.springer.com/article/10.1186/s13000-019-0842-0

Abstract Background Subjective qualitative descriptors are sometimes used to describe atypical breast lesions diagnosed on core needle biopsy (CNB) which are limited in extent. In clinical practice, this terminology is used to imply a lower expected risk of upgrade on surgical excision (EXC). It is uncertain how subjective terminology impacts clinical management. Methods We conducted a retrospective review of CNB with atypia and compared the EXC and upgrade rates of atypical ductal hyperplasia (ADH) and flat epithelial atypia (FEA) to lesions described as “focal” atypical ductal hyperplasia (FADH), to determine the impact of this diagnostic phrasing on surgical management and risk of malignancy. Results FADH and ADH were excised at similar rates (82% vs. 78%). FADH lesions showed a similar upgrade rate (13%) compared to non-focal ADH (10%), and both showed a trend towards higher upgrade and EXC rates compared to FEA. ADH, FADH and FEA all had an upgrade risk that warranted EXC. In non-upgraded EXC, for each diagnostic category we observed similar rates of residual atypia in the EXC. Conclusions Pathologists should avoid the use of qualitative descriptors when describing ADH on CNB because of the potential of this terminology to influence clinical decision making which is unwarranted.